Stage I Diagnostics Inc. is a leading innovator of biomarker detection assays for research.  To date we have developed unique antibodies and recombinant proteins to eight biomarkers, which have been indicated for use in multiple fields including oncology.  The seven Biomarkers are KLK6, KLK7, KLK8, Matriptase, MMP-7, Hepsin, ALP, and TMPRSS3.  These biomarkers have been linked to multiple cancer types including ovarian, prostate, cervical, and pancreatic cancers.  We offer individual antibodies, recombinant proteins, ELISA kits for serum detection, and custom assay services.

Stage I Markers’ Potential for Other Cancers